Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Disease Control and Prevention Vaccine Market 2018, Forecast to 2023
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
Scope of the Report:
This report focuses on the Disease Control and Prevention Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Disease Control and Prevention Vaccine is expected to grow at a CAGR of roughly 12.0% over the next five years, will reach 81100 million US$ in 2023, from 41100 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Disease Control and Prevention Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Disease Control and Prevention Vaccine, with sales, revenue, and price of Disease Control and Prevention Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Disease Control and Prevention Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Disease Control and Prevention Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Disease Control and Prevention Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Disease Control and Prevention Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Disease Control and Prevention Vaccine is expected to grow at a CAGR of roughly 12.0% over the next five years, will reach 81100 million US$ in 2023, from 41100 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- GSK
- Merck & Co., Inc
- Pfizer
- Sanofi
- AstraZeneca PLC
- Sinovac Biotech Ltd
- Astellas Pharma Inc
- Serum Institute of India Pvt. Ltd
- Daiichi Sankyo
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Live-Attenuated
- Inactivated
- Recombinant Sub Unit and Toxoid
- Pediatric Vaccine
- Adult Vaccine
Chapter 1, to describe Disease Control and Prevention Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Disease Control and Prevention Vaccine, with sales, revenue, and price of Disease Control and Prevention Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Disease Control and Prevention Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Disease Control and Prevention Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Disease Control and Prevention Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Disease Control and Prevention Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Live-Attenuated
1.2.2 Inactivated
1.2.3 Recombinant Sub Unit and Toxoid
1.3 Market Analysis by Applications
1.3.1 Pediatric Vaccine
1.3.2 Adult Vaccine
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 Business Overview
2.1.1.1 GSK Description
2.1.1.2 GSK Headquarter, Main Business and Finance Overview
2.1.2 GSK Disease Control and Prevention Vaccine Product Introduction
2.1.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.1.2.2 Disease Control and Prevention Vaccine Product Information
2.1.3 GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global GSK Disease Control and Prevention Vaccine Market Share in 2017
2.2 Merck & Co., Inc
2.2.1 Business Overview
2.2.1.1 Merck & Co., Inc Description
2.2.1.2 Merck & Co., Inc Headquarter, Main Business and Finance Overview
2.2.2 Merck & Co., Inc Disease Control and Prevention Vaccine Product Introduction
2.2.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.2.2.2 Disease Control and Prevention Vaccine Product Information
2.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Merck & Co., Inc Disease Control and Prevention Vaccine Market Share in 2017
2.3 Pfizer
2.3.1 Business Overview
2.3.1.1 Pfizer Description
2.3.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.3.2 Pfizer Disease Control and Prevention Vaccine Product Introduction
2.3.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.3.2.2 Disease Control and Prevention Vaccine Product Information
2.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Pfizer Disease Control and Prevention Vaccine Market Share in 2017
2.4 Sanofi
2.4.1 Business Overview
2.4.1.1 Sanofi Description
2.4.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.4.2 Sanofi Disease Control and Prevention Vaccine Product Introduction
2.4.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.4.2.2 Disease Control and Prevention Vaccine Product Information
2.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sanofi Disease Control and Prevention Vaccine Market Share in 2017
2.5 AstraZeneca PLC
2.5.1 Business Overview
2.5.1.1 AstraZeneca PLC Description
2.5.1.2 AstraZeneca PLC Headquarter, Main Business and Finance Overview
2.5.2 AstraZeneca PLC Disease Control and Prevention Vaccine Product Introduction
2.5.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.5.2.2 Disease Control and Prevention Vaccine Product Information
2.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global AstraZeneca PLC Disease Control and Prevention Vaccine Market Share in 2017
2.6 Sinovac Biotech Ltd
2.6.1 Business Overview
2.6.1.1 Sinovac Biotech Ltd Description
2.6.1.2 Sinovac Biotech Ltd Headquarter, Main Business and Finance Overview
2.6.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Introduction
2.6.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.6.2.2 Disease Control and Prevention Vaccine Product Information
2.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Sinovac Biotech Ltd Disease Control and Prevention Vaccine Market Share in 2017
2.7 Astellas Pharma Inc
2.7.1 Business Overview
2.7.1.1 Astellas Pharma Inc Description
2.7.1.2 Astellas Pharma Inc Headquarter, Main Business and Finance Overview
2.7.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Introduction
2.7.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.7.2.2 Disease Control and Prevention Vaccine Product Information
2.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Astellas Pharma Inc Disease Control and Prevention Vaccine Market Share in 2017
2.8 Serum Institute of India Pvt. Ltd
2.8.1 Business Overview
2.8.1.1 Serum Institute of India Pvt. Ltd Description
2.8.1.2 Serum Institute of India Pvt. Ltd Headquarter, Main Business and Finance Overview
2.8.2 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Introduction
2.8.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.8.2.2 Disease Control and Prevention Vaccine Product Information
2.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Market Share in 2017
2.9 Daiichi Sankyo
2.9.1 Business Overview
2.9.1.1 Daiichi Sankyo Description
2.9.1.2 Daiichi Sankyo Headquarter, Main Business and Finance Overview
2.9.2 Daiichi Sankyo Disease Control and Prevention Vaccine Product Introduction
2.9.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.9.2.2 Disease Control and Prevention Vaccine Product Information
2.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Daiichi Sankyo Disease Control and Prevention Vaccine Market Share in 2017
3 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET COMPETITION, BY MANUFACTURER
3.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Disease Control and Prevention Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Disease Control and Prevention Vaccine Manufacturer Market Share in 2017
3.4.2 Top 5 Disease Control and Prevention Vaccine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET ANALYSIS BY REGIONS
4.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Disease Control and Prevention Vaccine Sales by Regions (2013-2018)
4.1.2 Global Disease Control and Prevention Vaccine Revenue by Regions (2013-2018)
4.2 North America Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
5.1.2 North America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
5.1.3 United States Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.1.4 Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.1.5 Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.2 North America Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
5.3.2 North America Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
5.4 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
5.4.2 North America Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
6.1.2 Europe Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
6.1.3 Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.4 UK Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.5 France Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.6 Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.7 Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.2 Europe Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
7.1.3 China Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.4 Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.5 Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.6 India Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
8.1.2 South America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
8.1.3 Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
8.1.4 Argentina Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
8.1.5 Colombia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
8.2 South America Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
8.3.2 South America Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
8.4 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
8.4.2 South America Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.4 UAE Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.5 Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.7 South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET SEGMENT BY TYPE
10.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Live-Attenuated Sales Growth and Price
10.2.1 Global Live-Attenuated Sales Growth (2013-2018)
10.2.2 Global Live-Attenuated Price (2013-2018)
10.3 Inactivated Sales Growth and Price
10.3.1 Global Inactivated Sales Growth (2013-2018)
10.3.2 Global Inactivated Price (2013-2018)
10.4 Recombinant Sub Unit and Toxoid Sales Growth and Price
10.4.1 Global Recombinant Sub Unit and Toxoid Sales Growth (2013-2018)
10.4.2 Global Recombinant Sub Unit and Toxoid Price (2013-2018)
11 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET SEGMENT BY APPLICATION
11.1 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2013-2018)
11.2 Pediatric Vaccine Sales Growth (2013-2018)
11.3 Adult Vaccine Sales Growth (2013-2018)
12 DISEASE CONTROL AND PREVENTION VACCINE MARKET FORECAST (2018-2023)
12.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Disease Control and Prevention Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.2 Europe Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.4 South America Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.3 Disease Control and Prevention Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Disease Control and Prevention Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Type (2018-2023)
12.4 Disease Control and Prevention Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Disease Control and Prevention Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Disease Control and Prevention Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Live-Attenuated
1.2.2 Inactivated
1.2.3 Recombinant Sub Unit and Toxoid
1.3 Market Analysis by Applications
1.3.1 Pediatric Vaccine
1.3.2 Adult Vaccine
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 Business Overview
2.1.1.1 GSK Description
2.1.1.2 GSK Headquarter, Main Business and Finance Overview
2.1.2 GSK Disease Control and Prevention Vaccine Product Introduction
2.1.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.1.2.2 Disease Control and Prevention Vaccine Product Information
2.1.3 GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global GSK Disease Control and Prevention Vaccine Market Share in 2017
2.2 Merck & Co., Inc
2.2.1 Business Overview
2.2.1.1 Merck & Co., Inc Description
2.2.1.2 Merck & Co., Inc Headquarter, Main Business and Finance Overview
2.2.2 Merck & Co., Inc Disease Control and Prevention Vaccine Product Introduction
2.2.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.2.2.2 Disease Control and Prevention Vaccine Product Information
2.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Merck & Co., Inc Disease Control and Prevention Vaccine Market Share in 2017
2.3 Pfizer
2.3.1 Business Overview
2.3.1.1 Pfizer Description
2.3.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.3.2 Pfizer Disease Control and Prevention Vaccine Product Introduction
2.3.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.3.2.2 Disease Control and Prevention Vaccine Product Information
2.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Pfizer Disease Control and Prevention Vaccine Market Share in 2017
2.4 Sanofi
2.4.1 Business Overview
2.4.1.1 Sanofi Description
2.4.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.4.2 Sanofi Disease Control and Prevention Vaccine Product Introduction
2.4.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.4.2.2 Disease Control and Prevention Vaccine Product Information
2.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sanofi Disease Control and Prevention Vaccine Market Share in 2017
2.5 AstraZeneca PLC
2.5.1 Business Overview
2.5.1.1 AstraZeneca PLC Description
2.5.1.2 AstraZeneca PLC Headquarter, Main Business and Finance Overview
2.5.2 AstraZeneca PLC Disease Control and Prevention Vaccine Product Introduction
2.5.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.5.2.2 Disease Control and Prevention Vaccine Product Information
2.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global AstraZeneca PLC Disease Control and Prevention Vaccine Market Share in 2017
2.6 Sinovac Biotech Ltd
2.6.1 Business Overview
2.6.1.1 Sinovac Biotech Ltd Description
2.6.1.2 Sinovac Biotech Ltd Headquarter, Main Business and Finance Overview
2.6.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Introduction
2.6.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.6.2.2 Disease Control and Prevention Vaccine Product Information
2.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Sinovac Biotech Ltd Disease Control and Prevention Vaccine Market Share in 2017
2.7 Astellas Pharma Inc
2.7.1 Business Overview
2.7.1.1 Astellas Pharma Inc Description
2.7.1.2 Astellas Pharma Inc Headquarter, Main Business and Finance Overview
2.7.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Introduction
2.7.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.7.2.2 Disease Control and Prevention Vaccine Product Information
2.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Astellas Pharma Inc Disease Control and Prevention Vaccine Market Share in 2017
2.8 Serum Institute of India Pvt. Ltd
2.8.1 Business Overview
2.8.1.1 Serum Institute of India Pvt. Ltd Description
2.8.1.2 Serum Institute of India Pvt. Ltd Headquarter, Main Business and Finance Overview
2.8.2 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Introduction
2.8.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.8.2.2 Disease Control and Prevention Vaccine Product Information
2.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Market Share in 2017
2.9 Daiichi Sankyo
2.9.1 Business Overview
2.9.1.1 Daiichi Sankyo Description
2.9.1.2 Daiichi Sankyo Headquarter, Main Business and Finance Overview
2.9.2 Daiichi Sankyo Disease Control and Prevention Vaccine Product Introduction
2.9.2.1 Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
2.9.2.2 Disease Control and Prevention Vaccine Product Information
2.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Daiichi Sankyo Disease Control and Prevention Vaccine Market Share in 2017
3 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET COMPETITION, BY MANUFACTURER
3.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Disease Control and Prevention Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Disease Control and Prevention Vaccine Manufacturer Market Share in 2017
3.4.2 Top 5 Disease Control and Prevention Vaccine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET ANALYSIS BY REGIONS
4.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Disease Control and Prevention Vaccine Sales by Regions (2013-2018)
4.1.2 Global Disease Control and Prevention Vaccine Revenue by Regions (2013-2018)
4.2 North America Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
5.1.2 North America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
5.1.3 United States Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.1.4 Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.1.5 Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.2 North America Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
5.3.2 North America Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
5.4 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
5.4.2 North America Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
6.1.2 Europe Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
6.1.3 Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.4 UK Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.5 France Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.6 Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.1.7 Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
6.2 Europe Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
7.1.3 China Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.4 Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.5 Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.6 India Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
8.1.2 South America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
8.1.3 Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
8.1.4 Argentina Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
8.1.5 Colombia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
8.2 South America Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
8.3.2 South America Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
8.4 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
8.4.2 South America Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DISEASE CONTROL AND PREVENTION VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.4 UAE Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.5 Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.1.7 South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Disease Control and Prevention Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Disease Control and Prevention Vaccine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Disease Control and Prevention Vaccine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Disease Control and Prevention Vaccine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET SEGMENT BY TYPE
10.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Live-Attenuated Sales Growth and Price
10.2.1 Global Live-Attenuated Sales Growth (2013-2018)
10.2.2 Global Live-Attenuated Price (2013-2018)
10.3 Inactivated Sales Growth and Price
10.3.1 Global Inactivated Sales Growth (2013-2018)
10.3.2 Global Inactivated Price (2013-2018)
10.4 Recombinant Sub Unit and Toxoid Sales Growth and Price
10.4.1 Global Recombinant Sub Unit and Toxoid Sales Growth (2013-2018)
10.4.2 Global Recombinant Sub Unit and Toxoid Price (2013-2018)
11 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET SEGMENT BY APPLICATION
11.1 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2013-2018)
11.2 Pediatric Vaccine Sales Growth (2013-2018)
11.3 Adult Vaccine Sales Growth (2013-2018)
12 DISEASE CONTROL AND PREVENTION VACCINE MARKET FORECAST (2018-2023)
12.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Disease Control and Prevention Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.2 Europe Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.4 South America Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Disease Control and Prevention Vaccine Market Forecast (2018-2023)
12.3 Disease Control and Prevention Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Disease Control and Prevention Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Type (2018-2023)
12.4 Disease Control and Prevention Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Disease Control and Prevention Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Disease Control and Prevention Vaccine Picture
Table Product Specifications of Disease Control and Prevention Vaccine
Figure Global Disease Control and Prevention Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Disease Control and Prevention Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Disease Control and Prevention Vaccine by Types in 2017
Figure Live-Attenuated Picture
Table Major Manufacturers of Live-Attenuated
Figure Inactivated Picture
Table Major Manufacturers of Inactivated
Figure Recombinant Sub Unit and Toxoid Picture
Table Major Manufacturers of Recombinant Sub Unit and Toxoid
Figure Disease Control and Prevention Vaccine Sales Market Share by Applications in 2017
Figure Pediatric Vaccine Picture
Figure Adult Vaccine Picture
Figure United States Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table GSK Disease Control and Prevention Vaccine Product
Table GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global GSK Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Merck & Co., Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck & Co., Inc Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Merck & Co., Inc Disease Control and Prevention Vaccine Product
Table Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck & Co., Inc Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Merck & Co., Inc Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Pfizer Disease Control and Prevention Vaccine Product
Table Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Pfizer Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Sanofi Disease Control and Prevention Vaccine Product
Table Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Sanofi Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table AstraZeneca PLC Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca PLC Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table AstraZeneca PLC Disease Control and Prevention Vaccine Product
Table AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca PLC Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global AstraZeneca PLC Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Sinovac Biotech Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Astellas Pharma Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Product
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Serum Institute of India Pvt. Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Daiichi Sankyo Headquarter, Established, Main Business and Finance Overview (2017)
Table Daiichi Sankyo Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Daiichi Sankyo Disease Control and Prevention Vaccine Product
Table Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Daiichi Sankyo Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Daiichi Sankyo Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Global Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Global Disease Control and Prevention Vaccine Price by Manufacturer (2016-2017)
Figure Top 3 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Global Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales by Regions (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales Market Share by Regions (2013-2018)
Table Global Disease Control and Prevention Vaccine Revenue by Regions (2013-2018)
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2013
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2017
Figure North America Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure North America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure South America Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure South America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure North America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2013
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table North America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2013
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure United States Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table North America Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2016
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure UK Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure France Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Europe Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Europe Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Europe Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Europe Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Countries 2017
Figure China Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure India Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure South America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table South America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure South America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure South America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table South America Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure South America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure South America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table South America Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Global Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Global Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Figure Global Live-Attenuated Sales Growth (2013-2018)
Figure Global Live-Attenuated Price (2013-2018)
Figure Global Inactivated Sales Growth (2013-2018)
Figure Global Inactivated Price (2013-2018)
Figure Global Recombinant Sub Unit and Toxoid Sales Growth (2013-2018)
Figure Global Recombinant Sub Unit and Toxoid Price (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Figure Global Pediatric Vaccine Sales Growth (2013-2018)
Figure Global Adult Vaccine Sales Growth (2013-2018)
Figure Global Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Forecast by Regions (2018-2023)
Table Global Disease Control and Prevention Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure Europe Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure South America Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Forecast by Type (2018-2023)
Table Global Disease Control and Prevention Vaccine Market Share Forecast by Type (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Forecast by Application (2018-2023)
Table Global Disease Control and Prevention Vaccine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Disease Control and Prevention Vaccine Picture
Table Product Specifications of Disease Control and Prevention Vaccine
Figure Global Disease Control and Prevention Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Disease Control and Prevention Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Disease Control and Prevention Vaccine by Types in 2017
Figure Live-Attenuated Picture
Table Major Manufacturers of Live-Attenuated
Figure Inactivated Picture
Table Major Manufacturers of Inactivated
Figure Recombinant Sub Unit and Toxoid Picture
Table Major Manufacturers of Recombinant Sub Unit and Toxoid
Figure Disease Control and Prevention Vaccine Sales Market Share by Applications in 2017
Figure Pediatric Vaccine Picture
Figure Adult Vaccine Picture
Figure United States Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table GSK Disease Control and Prevention Vaccine Product
Table GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global GSK Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Merck & Co., Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck & Co., Inc Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Merck & Co., Inc Disease Control and Prevention Vaccine Product
Table Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck & Co., Inc Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Merck & Co., Inc Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Pfizer Disease Control and Prevention Vaccine Product
Table Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Pfizer Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Sanofi Disease Control and Prevention Vaccine Product
Table Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Sanofi Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table AstraZeneca PLC Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca PLC Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table AstraZeneca PLC Disease Control and Prevention Vaccine Product
Table AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca PLC Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global AstraZeneca PLC Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Sinovac Biotech Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Astellas Pharma Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Product
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Serum Institute of India Pvt. Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Daiichi Sankyo Headquarter, Established, Main Business and Finance Overview (2017)
Table Daiichi Sankyo Disease Control and Prevention Vaccine Production Bases, Sales Regions and Major Competitors
Table Daiichi Sankyo Disease Control and Prevention Vaccine Product
Table Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Daiichi Sankyo Disease Control and Prevention Vaccine Sales Market Share in 2017
Figure Global Daiichi Sankyo Disease Control and Prevention Vaccine Revenue Market Share in 2017
Table Global Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Global Disease Control and Prevention Vaccine Price by Manufacturer (2016-2017)
Figure Top 3 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Global Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales by Regions (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales Market Share by Regions (2013-2018)
Table Global Disease Control and Prevention Vaccine Revenue by Regions (2013-2018)
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2013
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2017
Figure North America Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure North America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure South America Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure South America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Figure North America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2013
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table North America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2013
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure United States Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table North America Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table North America Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table North America Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2016
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure UK Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure France Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Europe Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Europe Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Europe Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Europe Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Countries 2017
Figure China Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure India Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table Asia-Pacific Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure South America Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table South America Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure South America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure South America Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table South America Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure South America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure South America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table South America Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table South America Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table South America Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Application (2013-2018)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Share by Application (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales by Type (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Table Global Disease Control and Prevention Vaccine Revenue by Type (2013-2018)
Table Global Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Figure Global Live-Attenuated Sales Growth (2013-2018)
Figure Global Live-Attenuated Price (2013-2018)
Figure Global Inactivated Sales Growth (2013-2018)
Figure Global Inactivated Price (2013-2018)
Figure Global Recombinant Sub Unit and Toxoid Sales Growth (2013-2018)
Figure Global Recombinant Sub Unit and Toxoid Price (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales by Application (2013-2018)
Table Global Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Figure Global Pediatric Vaccine Sales Growth (2013-2018)
Figure Global Adult Vaccine Sales Growth (2013-2018)
Figure Global Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Forecast by Regions (2018-2023)
Table Global Disease Control and Prevention Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure Europe Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure South America Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Disease Control and Prevention Vaccine Market Forecast (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Forecast by Type (2018-2023)
Table Global Disease Control and Prevention Vaccine Market Share Forecast by Type (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Forecast by Application (2018-2023)
Table Global Disease Control and Prevention Vaccine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List